Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.
about
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activationPeripheral cannabinoid receptor, CB2, regulates bone mass.CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioidsCannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responsesInterferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic painCrucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic painCB2 receptor-mediated migration of immune cells: it can go either wayEmerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammationThe endocannabinoid system as an emerging target of pharmacotherapyThe orphan receptor GPR55 is a novel cannabinoid receptorReduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptorNovel cannabinoid receptorsActivation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNSDelta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitroCB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseaseBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemEndogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulationsExpression Analysis of CB2-GFP BAC Transgenic MiceWhat we know and do not know about the cannabinoid receptor 2 (CB2)Interaction between Cannabinoid System and Toll-Like Receptors Controls InflammationThe CB2 receptor and its role as a regulator of inflammationCannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the HippocampusNeuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brainThe synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic painBrain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjectsFunctional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depressionCannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated ratsThe evolution and comparative neurobiology of endocannabinoid signallingCB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory.Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice.Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development.Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.Diabetic retinopathy: current management and experimental therapeutic targets.Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisCB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells(-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation.
P2860
Q21245246-EEA41D84-C8AE-456C-AD53-27BE85EB4E94Q24536360-5AEF6752-D447-4400-B5A1-AF8C90E2D3FBQ24556619-FAED207D-281D-4570-BB69-E15F1D631258Q24633610-E265B5EF-BBD6-489A-8CEC-F74229C02D64Q24634125-E88C139A-EAE2-43AE-B5EE-C1D65700BB65Q24634161-9824C409-D6E1-4B28-9E7B-3B0671FDC3F1Q24643591-F9B1B1B2-0741-4992-9A12-C088645119FCQ24647850-B6B49B07-3094-41AD-B7A0-67F66D64655DQ24648473-18DBAE70-69F1-4E89-A550-C9F88D9D22FEQ24670137-DACC97E2-AF20-4476-8A30-BC3B2120E0E3Q24672600-BDAD6C6D-BC30-4345-94F2-7366AD89F09CQ24681482-94E373BF-76AF-42F3-81A0-485A7B0B1139Q24683100-F9D7B8C8-A29A-4ABA-84EE-8D1215AB7A72Q24797076-1E858693-57EB-4135-B015-B8705FCA34EFQ26746050-70C221BD-7583-43A0-9B9B-04E74CC18760Q26865295-0F91C6F0-1F9A-4458-8DB5-02A7FBDC4068Q27009220-D89768B6-F374-4A16-98F2-F6D3CC54DCAEQ27316448-FDD37689-6020-4B36-A213-70C66DDF1F8AQ27686851-5A0314DF-FAB5-464C-BB48-949DC550842BQ28066215-52866352-3F02-4CD8-963E-A40BFC93A36EQ28066700-6F2F4BCD-1E73-468F-9A39-9D022087C44BQ28275230-87112B65-9059-4EF6-B888-72D1B6A6F8AAQ28292744-1B1AC607-7D42-4C6A-B5EC-5432FBE0F572Q28366593-D82A6D91-5618-490A-8294-A9B0817E24B1Q28472191-764599A6-7127-4C8C-9B13-FF92FF41937FQ28566269-F3558D65-0096-451F-AC60-F5410883451DQ28568772-2BF34C40-1888-4E53-8C6C-14C472B39D27Q28714675-F56FAC0F-3D7B-4DAB-860F-13BA5FD05577Q30392902-82BDD3D7-C26E-480A-A10F-B773D09FCEF6Q30467190-36BC74F3-356C-4413-B88F-368352FB1DB6Q30497010-00EC44CA-CCC2-4610-9F2B-ADAC5DA2E62EQ31522100-4E82B92C-531E-4F1B-A56A-89D2A5157848Q33291748-D05B9EAE-0C50-4D68-8866-12A90D1EA1B9Q33403016-AD8CDA12-7385-4A78-8395-9E518CDF7E0EQ33464957-C0E3CC1C-0119-4707-B127-466B83BE32B6Q33488512-7D8C4591-0CEA-4B9F-80EA-E277A1A85BC0Q33581824-4882436A-ABFC-4EF0-95A8-0C7908AB9792Q33624245-DFF89731-5C47-41B9-8AF5-79DD0E9EAC6DQ33664105-204E0579-7BE1-4F1E-9ACB-F90035778989Q33749455-F08356C7-46F9-44A4-97C5-E8E10063429B
P2860
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB
@nl
Immunomodulation by cannabinoi ...... he cannabinoid CB(2) receptor.
@en
type
label
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB
@nl
Immunomodulation by cannabinoi ...... he cannabinoid CB(2) receptor.
@en
prefLabel
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB
@nl
Immunomodulation by cannabinoi ...... he cannabinoid CB(2) receptor.
@en
P2093
P921
P1476
Immunomodulation by cannabinoi ...... he cannabinoid CB(2) receptor.
@en
P2093
P304
P356
10.1016/S0014-2999(00)00211-9
P407
P577
2000-05-01T00:00:00Z